Welcome To Iconocast

How to add a URL link from your web site to the Iconocast web sites

Virtual tour of Southern California

Recent News and Articles on the Keywords: 0.33 + web  Related to the article below (Last Update: 8/4/2008)

Web.com Reports Second Quarter 2008 Financial Results istockAnalyst.com, OR - "Despite challenging economic conditions, Web.com was able to hit the top of its quarterly revenue and earnings guidance. The operating leverage potential ... Puget Energy Reports Second Quarter 2008 Financial Results WELT ONLINE, Germany - Second Quarter 2007 EPS Reconciliation Cents per diluted share Puget Energy?s second quarter 2007 earnings from PSE $ 0.33 Increase in natural gas margin ...PSD Prophecy drills 45.5 metres of 0.33% copper and 0.003% Molybdenum ... Canada NewsWire (press release), Canada - Jul 28, 2008 For further information: about Prophecy, please visit our web site at www.prophecyresource.com or contact us toll-free at (888) 818-8748.CVE:PCY - TSE:X - CVE:ETF Plum Creek Timber Company, Inc. Reports Results for Second Quarter ... MarketWatch - Jul 28, 2008 A live webcast of the conference call may be accessed through Plum Creek's Web site at www.plumcreek.com by clicking on the "Investors" link. ...PCL WELT ONLINE Aladdin Knowledge Systems Reports Second Quarter 2008 Financial ... MarketWatch - Jul 21, 2008 Released Aladdin eSafe v6.2 Proxy, offering organizations more options in control and flexibility for secure Web gateway deployment. ... Leadis Technology Reports Second Quarter 2008 Results MarketWatch all 773 news articles »  LDIS - ALDN CPI Financial Peapack-Gladstone Financial Corporation Reports 27% Increase in ... MarketWatch - Aug 1, 2008 To learn more about Peapack-Gladstone Financial Corporation and its services please visit our web site at www.pgbank.com or call 908-234-0700. ... Bank of Hawaii Corporation Second Quarter 2008 Financial Results Trading Markets (press release) Greene County Bancorp, Inc. Announces Earnings Increase MarketWatch all 963 news articles »  GCBC - BOH - PGC Waddell & Reed Financial, Inc. Reports Second Quarter Results MarketWatch - Jul 29, 2008 Live access to the teleconference will be available on the "Corporate" section of our Web site at http://www.waddell.com. A Web cast replay will be made ...WDR American Equity Reports Second Quarter 2008 Operating Income of ... WELT ONLINE, Germany - Jul 30, 2008 An audio replay will be available shortly after the call on AEL?s web site. An audio replay will also be available via telephone through August 21, ...AEL Digital River Announces Second Quarter Financial Results MarketWatch - Jul 30, 2008 A webcast replay of the call will be archived on Digital River's corporate Web site. Digital River, Inc., a leading provider of global e-commerce solutions, ...DRIV Kaboose Reports Record Second Quarter 2008 Results with Revenue ... Canada NewsWire (press release), Canada - Jul 31, 2008 The webcast will be archived on the same web page for 30 days following the live call. The second quarter financial statements and related management's ...TSE:KAB - BOM:532354 - GIS

Interruptions In Antiretroviral Treatment Increases Risk Of Developing AIDS-Related Diseases, Can Be Fatal, Study Says

Article Date: 04 Dec 2006 - 1:00am (PST)

Interruptions in an HIV-positive person's antiretroviral treatment regimen can increase the risk of developing AIDS-related diseases and sometimes can be fatal, according to a study published Thursday in the New England Journal of Medicine, the Los Angeles Times reports. The study -- known as Strategies for Management of Antiretroviral Therapy, or SMART -- was led by NIH and involved 5,472 HIV-positive people in 33 countries (Chong, Los Angeles Times, 11/30). The study began in January 2002 but was halted at the beginning of this year after preliminary results indicated that the mortality rates among the 2,720 participants who were in the treatment-interruption group were significantly higher, the San Francisco Chronicle reports. According to the Chronicle, participants in the treatment-interruption group stopped taking antiretrovirals when their CD4+ T cell counts were above 400 and restarted drug therapy when their T cell counts were below 250.

The study found that those in the treatment-interruption group were 1.9 times more likely to die and had a substantially higher risk of becoming ill from AIDS-related diseases compared with those who did not interrupt their antiretroviral regimens (Russell, San Francisco Chronicle, 11/30). According to the study, 120 participants in the treatment-interruption group died or developed AIDS-related diseases, while 47 participants in the continuous-treatment group died during the study period (Los Angeles Times, 11/30). The study also found that 8% of all deaths were caused by AIDS-related diseases. The most common known cause of death among the participants was cancer, followed by cardiovascular disease and complications from substance abuse, the study found (San Francisco Chronicle, 1130).

Article continues below and (thank you)

In addition, participants in the treatment-interruption group were 1.8 times more likely to develop serious kidney, heart or liver problems than the continuous-treatment group. Although researchers expected the rate of cardiovascular disease to be lower in the treatment-interruption group because heart problems are commonly reported side effects of antiretrovirals, the study found that 48% of participants in the treatment-interruption group developed cardiovascular problems, compared with 31% in the continuous-treatment group (Los Angeles Times, 11/30).

Reaction
Donald Abrams, a researcher at the University of California-San Francisco, said it was difficult to explain why more people died in the treatment-interruption group because the actual number of deaths was low, the Chronicle reports. He added that one reason is that HIV or the inflammation it causes can negatively affect HIV-positive people in ways not fully understood (San Francisco Chronicle, 11/30). "This was a big surprise," James Neaton of the University of Minnesota said, adding, "Treatment may increase the risk" of heart, liver and kidney disease, "but the absence of treatment appears to increase the risk even more" (Emery, Reuters U.K., 11/29). Anthony Fauci, director of NIH's National Institute of Allergy and Infectious Diseases, said, "I think, for practical purposes, this is the end" of the stop-and-start antiretroviral treatment strategy (Los Angeles Times, 11/30).

Additional Articles
NEJM in its Nov. 30 issue ran other HIV/AIDS-related articles. Headlines appear below.

• "HIV/AIDS in Tanzania -- Realities on the Ground" (Zeeman, NEJM, 11/30).
  
  
• "Getting Smarter -- The Toxicity of Undertreated HIV Infection" (Currier/Baden, NEJM, 11/30).
  
  
• "Pioneers in AIDS Care -- Reflections on the Epidemic's Early Years" (Bayer/Oppenheimer, NEJM, 11/30).